Company intelligence / Profile preview
Precigen
Germantown, Maryland, United Statesprecigen.com ↗
- Ownership
- Public · PGEN
- Employees
- ~600
- Development stage
- Phase 3
01
Overview
Precigen has demonstrated early clinical activity in several programs. For example, its PRGN‑3006 UltraCAR-T for AML/MDS received orphan drug status from the FDA. The company’s pipeline includes multiple gene and cell therapy candidates targeting both hematologic malignancies and solid tumors as well as autoimmune and infectious diseases. Several programs are in Phase 1/2 clinical trials with promising initial safety and efficacy data reported for some candidates
- Therapeutic areas
- GastroenterologyOncologyImmunologyInfectious Diseases
- Modalities
- Gene therapiescell therapies (including CAR-T)immunotherapies
- Industry
- Biotech
02
Drug pipeline
21 assets20 more assets in the full pipeline.
03
Partnerships
Not specifically listed in search results; historically partnered with various biotech firms under Intrexon.
04
Financials
- Market cap
- $1.5B
- Total revenue
- $9.7M
- Enterprise value
- $1.6B
Beyond the preview
Go deeper on Precigen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Precigen.